Diagnostic significance of high mobility group I(Y) protein expression in intraductal papillary mucinous tumors of the pancreas

Pancreas

Volumn 25, Issue 2, 2002, Pages 198-204

  Abe, Nobutsugu ^a   Watanabe, Takashi ^a   Izumisato, Yumi ^a   Masaki, Tadahiko ^a   Mori, Toshiyuki ^a   Sugiyama, Masanori ^a   Chiappetta, Gennaro ^a   Fusco, Alfredo ^a   Fujioka, Yasunori ^a   Atomi, Yutaka ^a  

^a KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Diagnostic marker; High Mobility Group I(Y); Immunohistochemical analysis; Intraductal papillary mucinous tumor of the pancreas

Indexed keywords

TUMOR MARKER;

ARTICLE; CANCER INVASION; CARCINOGENESIS; CARCINOMA IN SITU; CONTROLLED STUDY; DIAGNOSTIC TEST; DYSPLASIA; FISHER EXACT TEST; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALIGNANT TRANSFORMATION; PANCREAS CARCINOMA; PANCREAS DUCT; PANCREAS TUMOR; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOCARCINOMA, MUCINOUS; CARCINOMA, PANCREATIC DUCTAL; CARCINOMA, PAPILLARY; HMGA1A PROTEIN; HUMANS; IMMUNOHISTOCHEMISTRY; PANCREATIC NEOPLASMS;

EID: 0036312129     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-200208000-00015     Document Type: Article

References (39)

1. Intraductal papillary-mucinous tumors of the pancreas: Clinicopathologic features, outcome, and nomenclature
2. Pancreatic mucinous ductal ectasia and intraductal papillary neoplasm: A single malignant clinicopathologic entity
3. Four cases of "mucin-producing" cancer of the pancreas on specific findings of the papilla Vater
4. Intraductal papillary neoplasms of the pancreas: A clinicopathologic study of six patients
5. Intraductal papillary mucinous tumors of the pancreas: Clinical and therapeutic issues in 32 patients
6. Two types of mucin-producing cystic tumors of the pancreas: Diagnosis and treatment
7. Intraductal papillary mucinous tumors of the pancreas: Imaging studies and treatment strategies
8. Intraductal papillary mucinous tumors represent a distinct group of pancreatic neoplasms: An investigation of tumor cell differentiation and K-ras, p53, and c-erbB-2 abnormalities in 26 patients
9. Intraductal papillary-mucinous neoplasm of the pancreas
10. Complete murine cDNA sequence, genomic structure, and tissue expression of the high mobility group protein HMGI(Y)
11. cDNA cloning of the HMGI-C phosphoprotein, a nuclear protein associated with neoplastic and undifferentiated phenotypes
12. The AT DNA binding domain of mammalian high mobility group I chromosomal proteins: A novel peptide motif for recognizing DNA structure
13. High-mobility-group chromosomal proteins: Architectural components that facilitate chromatin function
14. Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C
15. High level expression of the HMGI(Y) gene during embryonic development
16. Detection of high mobility group I(Y) HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma
17. Increased expression of high mobility group protein I(Y) in high grade prostatic cancer determined by in situ hybridization
18. A retrospective study of high mobility group protein I(Y) as progression marker for prostate cancer determined by in situ hybridization
19. Expression of HMGI(Y) proteins in squamous intraepithelial and invasive lesions of the uterine cervix
20. Human colorectal carcinomas express high levels of high mobility group HMGI(Y) proteins
21. Determination of high mobility group I(Y) expression level in colorectal neoplasias: A potential diagnostic marker
22. Expression of the HMGI(Y) gene in human colorectal cancer
23. High mobility group HMGI(Y) protein expression in human colorectal hyperplastic and neoplastic diseases
24. Pancreatic duct cell carcinomas express high levels of high mobility group I(Y) (HMGI(Y)) proteins
25. Inhibition of HMGI-C protein synthesis suppresses retrovirally induced neoplastic transformation of rat thyroid cells
26. HMG-I/Y, a new c-Myc target gene and potential oncogene
27. Adenovirus-mediated suppression of HMGI(Y) protein synthesis as potential therapy of human malignant neoplasias
28. Immunohistochemical analysis of cyclooxygenase-2 expression in pancreatic tumors
29. Mucin-producing neoplasms of the pancreas
30. Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving?
31. Long-term survival after curative resection for pancreatic ductal adenocarcinoma: Clinicopathologic analysis of 5-year survivors
32. Spectrum of cystic tumors of the pancreas
33. Characteristics of cystic neoplasms of the pancreas and results of aggressive surgical treatment
34. Elevated high mobility group I(Y) gene expression is associated with progressive transformation of mouse mammary epithelial cells
35. Identification of high mobility group protein I(Y) as potential progression marker for prostate cancer by differential hybridization analysis
36. Intraductal papillary mucinous tumors of the pancreas: Evaluation with endoscopic ultrasonography
37. Intraductal papillary mucinous tumors of the pancreas: Evaluation with magnetic resonance cholangiopancreatography
38. Neoplastic transformation of rat thyroid cells requires the junB and fra-1 gene induction which is dependent on the HMGI-C gene product